These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4119234)

  • 1. The platelet as an inflammatory cell.
    Nachman RL; Weksler B
    Ann N Y Acad Sci; 1972 Oct; 201():131-7. PubMed ID: 4119234
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of PMN-leukocyte lysosomes in tissue injury, inflammation and hypersensitivity. 8. Mode of action and properties of vascular permeability factors released by PMN-leukocytes during 'in vitro' phagocytosis.
    Movat HZ; Macmorine DR; Takeuchi Y
    Int Arch Allergy Appl Immunol; 1971; 40(2):218-35. PubMed ID: 4100681
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of human platelet vascular permeability-enhancing activity.
    Nachman RL; Weksler B; Ferris B
    J Clin Invest; 1972 Mar; 51(3):549-56. PubMed ID: 4110899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit platelet bactericidal protein.
    Weksler BB; Nachman RL
    J Exp Med; 1971 Nov; 134(5):1114-30. PubMed ID: 5000106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing latephase reactions.
    Oertel HL; Kaliner M
    J Immunol; 1981 Oct; 127(4):1398-402. PubMed ID: 7276564
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of permeability factors from rabbit neutrophils.
    Ranadive NS; Cochrane CG
    J Exp Med; 1968 Oct; 128(4):605-22. PubMed ID: 4175322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased vascular permeability produced by human platelet granule cationic extract.
    Nachman RL; Weksler B; Ferris B
    J Clin Invest; 1970 Feb; 49(2):274-81. PubMed ID: 4391559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat.
    Janoff A; Schaefer S; Scherer J; Bean MA
    J Exp Med; 1965 Nov; 122(5):841-51. PubMed ID: 4379082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isolation from spleen tissue of high molecular weight proteins which alter vascular permeability: investigation of their pharmacological properties.
    Davies HS; Hartley RE; Schild HO
    Agents Actions; 1974 Apr; 4(2):84-94. PubMed ID: 4135431
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine-liberating activity of serum protein exposed to DEAE-cellulose.
    Levy M; Bliss JQ
    Can J Physiol Pharmacol; 1967 May; 45(3):479-89. PubMed ID: 4166543
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of histamine from rabbit blood platelets in vitro.
    Tuomisto J
    Ann Med Exp Biol Fenn; 1968; 46(3):318-29. PubMed ID: 4183306
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood platelets and the inflammatory process.
    Silver MJ; Smith JB; Ingerman CM
    Agents Actions; 1974 Oct; 4(4):233-40. PubMed ID: 4447066
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation of histamine liberating and vascular permeability increasing polypeptides from lysosomal granules of polymorphonuclear leukocytes in circulating bovine blood].
    Frimmer M; Lutz F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(2):297-313. PubMed ID: 4181231
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of BP 400, an antiamine, on skin histamine and polymyxin B induced wealing.
    Sondergaard J; Castellani T; Henningsen SJ; Zachariae H
    Acta Allergol; 1968 Sep; 23(3):282-6. PubMed ID: 4179759
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STUDIES ON THE LOCALIZATION OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES AND OTHER MACROMOLECULES IN VESSELS. II. PATHOGENETIC AND PHARMACODYNAMIC STUDIES.
    COCHRANE CG
    J Exp Med; 1963 Oct; 118(4):503-13. PubMed ID: 14067902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic proteins in rat neutrophils that increase vascular permeability.
    Ranadive NS; Cochrane CG
    Clin Exp Immunol; 1970 Jun; 6(6):905-11. PubMed ID: 4097809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelations between different typs of cells. I. A comparative study of the biological properties of a cationic polypeptide from lysosomes of polymorphonuclear leukocytes and other cationic compounds.
    Keller R; Mueller-Eckhardt C; Kayser FH; Keller HU
    Int Arch Allergy Appl Immunol; 1968; 33(3):239-58. PubMed ID: 4171930
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravital microscopic studies on acute mast cell-dependent inflammation.
    Raud J
    Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on the role of neutrophils in passive cutaneous anaphylaxis of the guinea-pig.
    Taichman NS; Movat HZ; Glynn MF; Broder I
    Immunology; 1971 Oct; 21(4):623-35. PubMed ID: 4107743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.